Development of a nutritional screening and assessment indicator system for patients with esophageal cancer in China: Findings from the Delphi method.
Delphi method
esophageal cancer
index system
nutritional assessment
nutritional screening
Journal
Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310
Informations de publication
Date de publication:
21 Nov 2023
21 Nov 2023
Historique:
revised:
14
10
2023
received:
21
06
2023
accepted:
24
10
2023
medline:
22
11
2023
pubmed:
22
11
2023
entrez:
22
11
2023
Statut:
aheadofprint
Résumé
In China, individuals diagnosed with esophageal cancer are confronted with an elevated risk of nutritional inadequacy or malnutrition throughout the course of their disease, a condition that contributes to various adverse clinical outcomes. A vast corpus of data are burgeoning at an unprecedented rate, primarily due to the revolutionary growth of digitalization technologies and artificial intelligence, notably within the domains of health care and medicine. The purpose of this investigation is to initiate the development of a nutritional screening and assessment indicator framework for patients with esophageal cancer within the Chinese context. We seek to furnish an instrumental reference to facilitate preparations for the forthcoming era of advanced, "deep," evidence-based medicine. An integrative methodology was employed to forge the preliminary draft of the nutritional screening and assessment indicator system for preoperative patients with esophageal cancer. This encompassed a rigorous literature survey, in-depth clinical practice investigation, and the facilitation of expert panel discussions. Thereafter, two iterative consultation phases were conducted using the Delphi method in China. The analytic hierarchy process was deployed to ascertain the weighting of each index within the definitive evaluation indicator system. The effective response rates for the dual rounds of expert consultation were 91.7% and 86.4%, with commensurate authority coefficients of 0.97 and 0.91. The Kendall harmony coefficients were ascertained to be 0.19 and 0.14 (p < 0.01), respectively. The culminating nutritional screening and assessment indicator system for patients with esophageal cancer comprised 5 primary-level indicators and 38 secondary-level indicators. The nutritional screening and assessment indicator system contrived for patients with esophageal cancer is underpinned by cogent theoretical principles, leverages an astute research methodology, and manifests dependable outcomes. This system may be appositely utilized as a meaningful reference for the nutritional screening and assessment process in patients afflicted with esophageal cancer.
Sections du résumé
BACKGROUND
BACKGROUND
In China, individuals diagnosed with esophageal cancer are confronted with an elevated risk of nutritional inadequacy or malnutrition throughout the course of their disease, a condition that contributes to various adverse clinical outcomes. A vast corpus of data are burgeoning at an unprecedented rate, primarily due to the revolutionary growth of digitalization technologies and artificial intelligence, notably within the domains of health care and medicine. The purpose of this investigation is to initiate the development of a nutritional screening and assessment indicator framework for patients with esophageal cancer within the Chinese context. We seek to furnish an instrumental reference to facilitate preparations for the forthcoming era of advanced, "deep," evidence-based medicine.
METHODS
METHODS
An integrative methodology was employed to forge the preliminary draft of the nutritional screening and assessment indicator system for preoperative patients with esophageal cancer. This encompassed a rigorous literature survey, in-depth clinical practice investigation, and the facilitation of expert panel discussions. Thereafter, two iterative consultation phases were conducted using the Delphi method in China. The analytic hierarchy process was deployed to ascertain the weighting of each index within the definitive evaluation indicator system.
RESULTS
RESULTS
The effective response rates for the dual rounds of expert consultation were 91.7% and 86.4%, with commensurate authority coefficients of 0.97 and 0.91. The Kendall harmony coefficients were ascertained to be 0.19 and 0.14 (p < 0.01), respectively. The culminating nutritional screening and assessment indicator system for patients with esophageal cancer comprised 5 primary-level indicators and 38 secondary-level indicators.
CONCLUSIONS
CONCLUSIONS
The nutritional screening and assessment indicator system contrived for patients with esophageal cancer is underpinned by cogent theoretical principles, leverages an astute research methodology, and manifests dependable outcomes. This system may be appositely utilized as a meaningful reference for the nutritional screening and assessment process in patients afflicted with esophageal cancer.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Guangdong Medical Research Foundation
ID : A2022188
Organisme : Guangzhou Municipal Science and Technology Program key projects
ID : 202103000037
Informations de copyright
© 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Références
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-249. doi:10.3322/caac.21660
Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J-Peking. 2022;135:584-590. doi:10.1097/CM9.0000000000002108
Watanabe M, Otake R, Kozuki R, et al. Recent progress in multidisciplinary treatment for patients with esophageal cancer. Surg Today. 2020;50:12-20. doi:10.1007/s00595-019-01878-7
Hsu P, Chien L, Huang C, et al. Treatment patterns and outcomes in patients with esophageal cancer: An analysis of a multidisciplinary tumor board database. Ann Surg Oncol. 2022;29:572-585. doi:10.1245/s10434-021-10568-z
Mao YS, Gao SG, Li Y, et al. Hotspots and prospects of esophageal cancer research in China. Chin J Gastrointes Surg. 2023;26:307-311. doi:10.3760/cma.j.cn441530-20221222-00535 (in Chinese).
Cao J, Xu H, Li W, et al. Nutritional assessment and risk factors associated to malnutrition in patients with esophageal cancer. Curr Probl Cancer. 2021;45:100638. doi:10.1016/j.currproblcancer.2020.100638
Song C, Cao J, Zhang F, et al. Nutritional risk assessment by scored patient-generated subjective global assessment associated with demographic characteristics in 23,904 common malignant tumors patients. Nutr Cancer. 2019;71:50-60. doi:10.1080/01635581.2019.1566478
Wang P, Chen X, Liu Q, Liu X, Li Y. Good performance of the Global Leadership Initiative on Malnutrition criteria for diagnosing and classifying malnutrition in people with esophageal cancer undergoing esophagectomy. Nutrition. 2021;91-92:111420. doi:10.1016/j.nut.2021.111420
Movahed S, Varshoee Tabrizi F, Pahlavani N, et al. Comprehensive assessment of nutritional status and nutritional-related complications in newly diagnosed esophageal cancer patients: a cross-sectional study. Clin Nutr. 2021;40:4449-4455. doi:10.1016/j.clnu.2021.01.003
Molfino A, Imbimbo G, Laviano A. Current screening methods for the risk or presence of malnutrition in cancer patients. Cancer Manag Res. 2022;14:561-567. doi:10.2147/CMAR.S294105
Arends J, Baracos V, Bertz H, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017;36:1187-1196. doi:10.1016/j.clnu.2017.06.017
Deftereos I, Kiss N, Isenring E, Carter VM, Yeung JM. A systematic review of the effect of preoperative nutrition support on nutritional status and treatment outcomes in upper gastrointestinal cancer resection. Eur J Surg Oncol. 2020;46:1423-1434. doi:10.1016/j.ejso.2020.04.008
Santos IM, Mendes L, Carolino E, Santos CA. Nutritional status, functional status, and quality of life-what is the impact and relationship on cancer patients? Nutr Cancer. 2021;73:2554-2567. doi:10.1080/01635581.2020.1839520
CSON Oncology, CSFP Nutrition, NAST Oncologists. Guidelines for nutritional treatment of esophageal cancer patients. Chin J Clin Oncol. 2020;47:1-6. doi:10.3969/j.issn.1000-8179.2020.01.430 (in Chinese).
Muscaritoli M, Imbimbo G, Jager-Wittenaar H, et al. Disease-related malnutrition with inflammation and cachexia. Clin Nutr. 2023;42:1475-1479. doi:10.1016/j.clnu.2023.05.013
McGovern J, Dolan RD, Skipworth RJ, Laird BJ, McMillan DC. Cancer cachexia: a nutritional or a systemic inflammatory syndrome? Brit J Cancer. 2022;127:379-382. doi:10.1038/s41416-022-01826-2
Cederholm T, Barazzoni R, Austin P, et al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr. 2017;36:49-64. doi:10.1016/j.clnu.2016.09.004
Arends J, Strasser F, Gonella S, et al. Cancer cachexia in adult patients: ESMO clinical practice guidelines. ESMO Open. 2021;6:100092. doi:10.1016/j.esmoop.2021.100092
Webster JM, Kempen LJAP, Hardy RS, Langen RCJ. Inflammation and skeletal muscle wasting during cachexia. Front Physiol. 2020;11:597675. doi:10.3389/fphys.2020.597675
Anker MS, Holcomb R, Muscaritoli M, et al. Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review. J Cachexia Sarcopenia Muscle. 2019;10:22-34. doi:10.1002/jcsm.12402
Brown LR, Laird BJA, Wigmore SJ, Skipworth RJE. Understanding cancer cachexia and its implications in upper gastrointestinal cancers. Curr Treat Option Oncol. 2022;23:1732-1747. doi:10.1007/s11864-022-01028-1
McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr. 2009;12:223-226. doi:10.1097/MCO.0b013e32832a7902
Wang YF, An ZY, Lin DH, Jin WL. Targeting cancer cachexia: molecular mechanisms and clinical study. MedComm. 2022;3:e164. doi:10.1002/mco2.164
Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Therapeut. 2021;221:107753. doi:10.1016/j.pharmthera.2020.107753
de van der Schueren MAE, Keller H, Cederholm T, et al. Global Leadership Initiative on Malnutrition (GLIM): guidance on validation of the operational criteria for the diagnosis of protein-energy malnutrition in adults. Clin Nutr. 2020;39:2872-2880. doi:10.1016/j.clnu.2019.12.022
Balsano R, Kruize Z, Lunardi M, et al. Transforming growth factor-beta signaling in cancer-induced cachexia: from molecular pathways to the clinics. Cells-Basel. 2022;11:2671. doi:10.3390/cells11172671
Wu Q, Liu Z, Li B, Liu YE, Wang P. Immunoregulation in cancer-associated cachexia. J Adv Res. 2023. May 6:S2090-1232(23)00124-8. doi:10.1016/j.jare.2023.04.018
Muthanandam S, Muthu J. Understanding cachexia in head and neck cancer. Asia Pac J Oncol Nurs. 2021;8:527-538. doi:10.4103/apjon.apjon-2145
Diakowska D, Krzystek-Korpacka M, Markocka-Maczka K, Diakowski W, Matusiewicz M, Grabowski K. Circulating leptin and inflammatory response in esophageal cancer, esophageal cancer-related cachexia-anorexia syndrome (CAS) and non-malignant CAS of the alimentary tract. Cytokine. 2010;51:132-137. doi:10.1016/j.cyto.2010.05.006
Fouladiun M, Körner U, Bosaeus I, Daneryd P, Hyltander A, Lundholm KG. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care-correlations with food intake, metabolism, exercise capacity, and hormones. Cancer-Am Cancer Soc. 2005;103:2189-2198. doi:10.1002/cncr.21013
Mannelli M, Gamberi T, Magherini F, et al. The adipokines in cancer cachexia. Int J Mol Sci. 2020;21:4860. doi:10.3390/ijms21144860
Anandavadivelan P, Lagergren P. Cachexia in patients with oesophageal cancer. Nat Rev Clin Oncol. 2016;13:185-198. doi:10.1038/nrclinonc.2015.200
Mueller C, Compher C, Ellen DM. A.S.P.E.N. Clinical guidelines: Nutrition screening, assessment, and intervention in adults. JPEN J Parenter Enteral Nutr. 2011;35:16-24. doi:10.1177/0148607110389335
Taylor BE, McClave SA, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient. Crit Care Med. 2016;44:390-438. doi:10.1097/CCM.0000000000001525
Kondrup J. ESPEN guidelines for nutrition screening 2002. Clin Nutr. 2003;22:415-421. doi:10.1016/S0261-5614(03)00098-0
Hui Z, Yang W, Shao-yu MU, et al. Prevalence of nutritional risks, malnutrition and application of nutritional support rates at one Chongqing teaching hospital. Natl Med J China. 2012;92:3417-3419. doi:10.3760/cma.j.issn.0376-2491.2012.48.009 (in Chinese).
Bauer J, Capra S, Ferguson M. Use of the scored patient-generated subjective global assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr. 2002;56:779-785. doi:10.1038/sj.ejcn.1601412
CSONSC. Expert consensus on nutritional therapy for patients with malignant tumors. Chin Clin Oncol. 2012;17:59-73. doi:10.3969/j.issn.1009-0460.2012.01.013 (in Chinese).
Zhang XN, Jiang ZM, Wu HS, et al. NRS 2002 nutritional risk screening and GLIM step 2 for diagnosis of malnutrition (without FFMI currently). Chin J Clin Nutr. 2020;28:1-6. doi:10.3760/cma.j.cn115822-20190923-00141 (in Chinese).
Subbiah V. The next generation of evidence-based medicine. Nat Med. 2023;29:49-58. doi:10.1038/s41591-022-02160-z
Hohmann E, Cote MP, Brand JC. Research pearls: expert consensus based evidence using the Delphi method. Arthroscopy. 2018;34:3278-3282. doi:10.1016/j.arthro.2018.10.004
Nasa P, Jain R, Juneja D. Delphi methodology in healthcare research: how to decide its appropriateness. World J Methodol. 2021;11:116-129. doi:10.5662/wjm.v11.i4.116
Spranger J, Homberg A, Sonnberger M, Niederberger M. Reporting guidelines for Delphi techniques in health sciences: a methodological review. Z Evid Fortbild Qual Gesundhwes. 2022;172:1-11. doi:10.1016/j.zefq.2022.04.025
Niederberger M, Köberich S. Coming to consensus: the Delphi technique. Eur J Cardiovasc Nurs. 2021;20:692-695. doi:10.1093/eurjcn/zvab059
Deftereos I, Yeung JMC, Arslan J, et al. Assessment of nutritional status and nutrition impact symptoms in patients undergoing resection for upper gastrointestinal cancer: results from the multi-centre NOURISH point prevalence study. Nutrients. 2021;13:3349. doi:10.3390/nu13103349
Bossi P, Delrio P, Mascheroni A, Zanetti M. The spectrum of malnutrition/cachexia/sarcopenia in oncology according to different cancer types and settings: a narrative review. Nutrients. 2021;13:1980. doi:10.3390/nu13061980
Weixian W, Li Z, Fengqin Z, et al. Nutritional risk and associated factors in patients with primary liver cancer. J Nurs Sci. 2018;33:86-88. doi:10.3870/J.Issn.1001-4152.2018.19.086 (in Chinese).
Pianhong Z, Xian S, Xiaoxu H, et al. Expert consensus on scoring disease severity for nutrition risk screening. Zhejiang Med J. 2022;44:1351-1355. (in Chinese).
Hirano Y, Konishi T, Kaneko H, et al. Weight loss during neoadjuvant therapy and short-term outcomes after esophagectomy: a retrospective cohort study. Int J Surg. 2023;109:805-812. doi:10.1097/JS9.0000000000000311
Lyu J, Li T, Xie C, et al. Enteral nutrition in esophageal cancer patients treated with radiotherapy: a Chinese expert consensus 2018. Future Oncol. 2019;15:517-531. doi:10.2217/fon-2018-0697
Xu YC, Vincent JI. Clinical measurement properties of malnutrition assessment tools for use with patients in hospitals: a systematic review. Nutr J. 2020;19:106. doi:10.1186/s12937-020-00613-0
Serón-Arbeloa C, Labarta-Monzón L, Puzo-Foncillas J, et al. Malnutrition screening and assessment. Nutrients. 2022;14:2392. doi:10.3390/nu14122392
MacFarling Meure C, Steer B, Porter J. Interrelationships between dietary outcomes, readmission rates and length of stay in hospitalised oncology patients: a scoping review. Nutrients. 2023;15:400. doi:10.3390/nu15020400
Hiesmayr M, Schindler K, Pernicka E, et al. Decreased food intake is a risk factor for mortality in hospitalised patients: The NutritionDay survey 2006. Clin Nutr. 2009;28:484-491. doi:10.1016/j.clnu.2009.05.013
Martin L, Muscaritoli M, Bourdel Marchasson I, et al. Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi-cohort analysis. J Cachexia Sarcopenia Muscle. 2021;12:1189-1202. doi:10.1002/jcsm.12756
Cushman KE. Symptom management: a comprehensive approach to increasing nutritional status in the cancer patient. Semin Oncol Nurs. 1986;2:30-35. doi:10.1016/0749-2081(86)90006-9
Kubrak C, Olson K, Jha N, et al. Nutrition impact symptoms: key determinants of reduced dietary intake, weight loss, and reduced functional capacity of patients with head and neck cancer before treatment. Head Neck. 2010;32:290-300. doi:10.1002/hed.21174
Khorasanchi A, Nemani S, Pandey S, et al. Managing nutrition impact symptoms in cancer cachexia: a case series and mini review. Front Nutr. 2022;9:831934. doi:10.3389/fnut.2022.831934
MacLaughlin HL, Twomey J, Saunt R, et al. The nutrition impact symptoms (NIS) score detects malnutrition risk in patients admitted to nephrology wards. J Hum Nutr Diet. 2018;31:683-688. doi:10.1111/jhn.12553
Kubrak C, Olson K, Baracos VE. The head and neck symptom checklist©: an instrument to evaluate nutrition impact symptoms effect on energy intake and weight loss. Support Care Cancer. 2013;21:3127-3136. doi:10.1007/s00520-013-1870-z
Lindqvist C, Slinde F, Majeed A, Bottai M, Wahlin S. Nutrition impact symptoms are related to malnutrition and quality of life-a cross-sectional study of patients with chronic liver disease. Clin Nutr. 2020;39:1840-1848. doi:10.1016/j.clnu.2019.07.024
Noel CW, Forner D, Chepeha DB, et al. The Edmonton Symptom Assessment System: a narrative review of a standardized symptom assessment tool in head and neck oncology. Oral Oncol. 2021;123:105595. doi:10.1016/j.oraloncology.2021.105595
García Almeida JM, García García C, Vegas Aguilar IM, Bellido Castañeda V, Bellido Guerrero D. Morphofunctional assessment of patient nutritional status: a global approach. Nutr Hosp. 2021;38:592-600. doi:10.20960/nh.03378
White JV, Guenter P, Jensen G, et al. Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition. JPEN J Parenter Enteral Nutr. 2012;36:275-283. doi:10.1177/0148607112440285
Crestani MS, Grassi T, Steemburgo T. Methods of nutritional assessment and functional capacity in the identification of unfavorable clinical outcomes in hospitalized patients with cancer: a systematic review. Nutr Rev. 2022;80:786-811. doi:10.1093/nutrit/nuab090
Bahat G. Measuring calf circumference: a practical tool to predict skeletal muscle mass via adjustment with BMI. Am J Clin Nutr. 2021;113:1398-1399. doi:10.1093/ajcn/nqab107
Chen L, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21:300-307. doi:10.1016/j.jamda.2019.12.012
Cederholm T, Jensen GL, Correia MITD, et al. GLIM criteria for the diagnosis of malnutrition-a consensus report from the global clinical nutrition community. Clin Nutr. 2019;38:1-9. doi:10.1016/j.clnu.2018.08.002
Evans DC, Corkins MR, Malone A, et al. The use of visceral proteins as nutrition markers: an ASPEN position paper. Nutr Clin Pract. 2021;36:22-28. doi:10.1002/ncp.10588
Chiang HC, Lin MY, Lin FC, et al. Transferrin and prealbumin identify esophageal cancer patients with malnutrition and poor prognosis in patients with normal albuminemia: a cohort study. Nutr Cancer. 2022;74:3546-3555. doi:10.1080/01635581.2022.2079687
Keller U. Nutritional laboratory markers in malnutrition. J Clin Med. 2019;8:775. doi:10.3390/jcm8060775
Evans DC, Guenter P, Jensen G, Malone A. Response to “Low albumin levels should be interpreted, but not ignored”. Nutr Clin Pract. 2021;36:504. doi:10.1002/ncp.10648
Dioguardi FS. Low plasma albumin levels should be interpreted, but not ignored. Nutr Clin Pract. 2021;36:502-503. doi:10.1002/ncp.10619
Portuondo JI, Probstfeld L, Massarweh NN, et al. Malnutrition in elective surgery: how traditional markers might be failing surgeons and patients. Surgery. 2020;168:1144-1151. doi:10.1016/j.surg.2020.08.012